chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection site and area around it, approximately 2x2 inches, is warm to touch and itchy. No redness or swelling. Itching developed almost immediately after vaccination and has continued since.
Pt. reports development of hives same day as vaccine administration - Pt. did not contact our office until 10/6/09.
Low grade fever (approx 100), headaches, nasuea Treated with tylenol
It's been 10 days and I still have a headache that won't go away and pain in my joints.
Got the at 60 got shingles/Suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a 60-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 4 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reproted by the patient. The patient got the Shingles vaccine and 4 months later got shingles. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
pt recv vax 25FEB97 & 3MAR97 pt devel a rash;No further details were provided;
Three weeks post injection began having breathing difficulties.  At six weeks I went to the doctor where they checked my D Dimer.  Because D Dimer was high, I was sent to emergency room.  While in emergency room I was diagnosed with multiple blood clots in both lungs.
No additional adverse effects reported.; patients have been administered improperly stored vaccines; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. The case concerns 1 patient and 1 combination product. On 10-JUN-2020, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated (VAQTA) prefilled syringe injection, lot # S026003, expiration date 17-OCT-2020 (exact dose and injection site were not reported) for prophylaxis.  Administered dose of vaccine experienced the temperature excursion of below 36 degrees Fahrenheit (29.5 degrees Fahrenheit) for 10 minutes. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No additional adverse effects were reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S026003; expirationdate: 17-OCT-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2007USA001137: US-009507513-2007USA001778: US-009507513-2007USA001779: US-009507513-2007USA001780: US-009507513-2007USA001781: US-009507513-2007USA001782: US-009507513-2007USA001783:
Patient passed out 10 minutes after the vaccination and lost consciousness for around 5 minutes. She regain consciousness around 5 minutes later, and didn't know what had just happened.  Patient mentioned that she passed out before when she had her blood drawn.  Her only complained at that moment was she felt really hot
chills; headache; low fever; bodyaches/sore hurt to walk; legs hurt; hives all over my back; itchy; like burning; tingling; hot; red; This is a spontaneous report from a contactable consumer (patient). A 61-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EWO162), via an unspecified route of administration, administered in left arm on 10Apr2021 (at the age of 61-year-old) as dose 2, single for COVID-19 immunization at Workplace clinic. The patient was not pregnant at the time of vaccination. The patient medical history was not reported. Concomitant medication(s) included amlodipine (AMLODIPINE); topiramate (TOPAMAX). The patient previously took Depakote, levaquin, percocet [oxycodone hydrochloride;paracetamol] and experienced allergy. The patient's historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER8727), via an unspecified route of administration, administered in left arm on 20Mar2021 at 09:30 as dose 1, single for COVID-19 immunization and experienced fatigue. The patient did not take other vaccine in four weeks. The patient did not have covid prior vaccination and patient did not test for covid post vaccination. On 13Apr2021 the patient mentioned she had chills; headache; low fever; body aches; legs hurt; sore hurt to walk. The next day I was fine. The day after on Apr2021, she broke out in hives all over her back, Legs, her arms, her hands and was itchy, tingling, and hot, like burning also red. This went on for two days so far. I am still itchy. Event resulted to visit Doctor or other healthcare professional office/clinic. The patient did not receive any treatment for the adverse events. The outcome of the events chills, headache, low fever, body aches/sore hurt to walk, legs hurt was recovered on an unspecified date in 2021, hives all over my back, like burning, tingling, hot, red was unknown and itchy was not recovered.  No Follow-up attempts are possible. No further information is expected
I have had severe shortness of breath and breathlessness, chest pain, heart racing, heart fluttering, heart pounding, chest tightness, nausea, extreme fatigue, coughing, headache. I have no stamina at all, just slight exertion causes my heart to start racing and pounding, I can't climb stairs and I haven't been able to work in weeks, now I'm probably going to lose my job I fear and then will have no health insurance. I have more tests this week to try and find out if I have endocarditis, so I am racking up all kinds of bills. So far no one believes me or will help me! ALL of this started within a few days of the second Pfizer dose of COVID vaccine. Biggest mistake of my life. I feel like I'm dying and no one will help. You are literally killing me.
Nausea, diarrhea, fever, chills, body aches, headache
Narrative:  A 66yo F. with PMH of Osteoporosis, Cobalamin deficiency, Low Back Pain and Varicose Veins She presented to the ER with complains of light headedness and elevated BP after the second Pfizer Covid-19 vaccine per ED documentation she also admitted to stiffness and dizziness post the second vaccine in AM improved in PM Patient was observed her discharge dx was documented as suspected Vegal event after second Covid-19 vaccine
I experienced mild fatigue and chills about 12 hours after the shot.  No treatment necessary.  I woke up at approx. 1:30 am feeling very warm.  I got out of bed.  While in the bathroom, I began to feel very lightheaded and passed out while I was washing my hands.  My wife heard me crash to the floor.    I returned to consciousness but passed out again while trying to stand, unresponsive to my wife.  I returned to consciousness after about 1 minute.  I stayed sitting for several minutes while my wife brought me some water.  I felt thirsty and it's possible I was dehydrated, but I had been drinking fluids (water) the day before as normal.  Due to the two fainting spells and a possible head injury, I went to the Emergency Room for treatment at approx. 2 am.
Information has been received from a physician concerning a 12 month old female who in 1999, at 12 months of age, was vaccinated with Varivax. On 12-FEB-2007 the patient developed 'breakthrough". The final outcome was unknown at the time of this report. It is unknown if medical attention was sought. There was no product quality complaint. No further information is available.
Swollen lymph nodes in left arm; Nausea; Headache; Body aches; Dose number:3; This is a spontaneous report received from a non-contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 23-year-old female patient (not pregnant) received  bnt162b2 (BNT162B2), administered in left arm, administration date 28Nov2021 (Lot number: 33030BD) at the age of 23 years as dose 3, single for COVID-19 immunisation. Relevant medical history included: "None". Concomitant medications were not reported. Vaccination history included: bnt162b2 (BNT162B2, DOSE 1, SINGLE, Lot Number: EN6207, Route of administration: Unspecified, Anatomical site: left arm), administration date: 01Apr2021 when the patient was 23 years old and bnt162b2 (BNT162B2, DOSE 2, SINGLE, Lot Number: EW0164, Route of administration: Unspecified, Anatomical site: left arm), administration date: 20Apr2021, when the patient was 23 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 28Nov2021, outcome "unknown", described as "Dose received: 3"; LYMPHADENOPATHY (non-serious), NAUSEA (non-serious), HEADACHE (non-serious) and PAIN (non-serious) all with onset 29Nov2021, outcome "recovering" and all described as "Swollen lymph nodes in left arm, nausea, headache and body aches". Therapeutic measures were not taken as a result of lymphadenopathy, headache, nausea and pain.  Additional Information: The patient's known allergies were reported as not applicable. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
No additional AE reported; an expired dose of VARlVAX was inadvertently administered to a patient; Patient was vaccinated at 27-OCT-2004; This non-valid spontaneous report was received from a vaccine coordinator and refers to unspecified patient of unknown age. There was no information about the patient's concurrent conditions, allergies, drug reactions, concomitant therapies or medical history provided.  On 27-OCT-2021, the patient was inadvertently vaccinated with expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S033540, verified as valid, expiration date: 22-OCT-2021) in dose 0.5 milliliter for prophylaxis (dose number, route of administration and anatomical location were not reported) reconstituted with sterile diluent. The outcome of expired product administered was unknown. No additional adverse events reported.  This case was considered to be non-valid due to lack of patient's identifiers.  Follow-up information has been received from a nurse on 25-JAN-2022. The patient was 8-month-old female (born on 31-JAN-2004). Administration of expired varicella virus vaccine live (oka/merck)(VARIVAX) (lot# S033540, expiry date 22-OCT-2021) was confirmed to have been performed on 27-OCT-2004 (conflicting information, previously reported as 27-OCT-2021) (inappropriate age at vaccine administration), subcutaneously in patient's right arm. There was no adverse experience.  This report was considered to be valid, as the patient identifiers has been provided along with follow-up.
I am experiencing tingling on my scalp, around my eyes, and on my nose; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: UNKNOWN), via an unspecified route of administration in left arm on 16Mar2021 16:30 as single dose for COVID-19 immunization. Vaccination facility type: Pharmacy/Drug Store. The patient medical history included myasthenia gravis from an unknown date and unknown if ongoing , autoimmune disorder from an unknown date and unknown if ongoing. The patient concomitant medications included metformin (METFORMIN) taken for an unspecified indication, start and stop date were not reported; lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported. The patient received Metformin, Lisinopril, Dietary Sup., Herbal Rem within 2 weeks of vaccination. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the COVID vaccine. On 16Mar2021 16:30, the patient experienced: tingling on my scalp, around my eyes, and on my nose (paraesthesia) (non-serious). This events has been ongoing since the date of the vaccination. The patient did not receive any treatment for the events. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
I was fine with dose number one I only had some pain in my arm. With dose number two I had fainted the next morning. Had cold chills. Body aches. A severe headache and nausea.
Fatigue, headaches, glands are swollen, lethargic, exhaustion. shortness of breath, chills, and sore throat.
Information has ben received from a pharmacist referring to a patient of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On an unknown date, the patient was vaccinated with improperly stored ZOSTAVAX 19400 PFU (lot # M001747 with expiration date 07-APR-2017; dose and route were not reported). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Initial case report received from a nurse on 18 May 2010: This patient was inadvertently vaccinated with expired S-OIV FLUVIRIN, (batch no. 1013292P) 0.5 ml intramuscularly on an unspecified date. According to the reporter, no adverse events were noted after the vaccine administration. The outcome of the event was not reported.
Platelets dropped; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT DECREASED (Platelets dropped) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PLATELET COUNT DECREASED (Platelets dropped). At the time of the report, PLATELET COUNT DECREASED (Platelets dropped) outcome was unknown. Not Provided          No concomitant medications were provided by reporter. No treatment medications were reported.  This case concerns a patient of an unknown age and gender with no relevant medical history reported, who experienced the unexpected non-serious AESI event of platelet count decreased. The event occurred at an unknown day after the third dose of Moderna COVID-19 vaccine. The rechallenge was not applicable since the events happened after the third dose and no additional dosing is expected. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.; Sender's Comments: This case concerns a patient of an unknown age and gender with no relevant medical history reported, who experienced the unexpected non-serious AESI event of platelet count decreased. The event occurred at an unknown day after the third dose of Moderna COVID-19 vaccine. The rechallenge was not applicable since the events happened after the third dose and no additional dosing is expected. The benefit-risk relationship of Moderna COVID-19 vaccine is not affected by this report.
pt recv vax 1NOV98 & 2hr p/vax pt exp eye itching & burning, h/a & arm pain;pt sought unspecified medical attention;
This spontaneous report was received from a male patient of unknown age referring to himself. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On an unspecified date in 2016 (reported as "about two years"), the patient was vaccinated with the second dose of PNEUMOVAX 23 0.5 ml, for prophylaxis (route of administration, lot # and expiration date were not reported). It was reported that 5 or 6 days later, the patient went to play golf and blew out two tendons (tendon rupture) in his shoulder. It was unknown if any treatment was given for the event or if any laboratory/diagnostic test was performed. At the time of reporting, the outcome of the event was unknown.  The causality assessment between the event and PNEUMOVAX 23 was not provided.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The reported that he/she was had shingles vaccine and still experienced shingles. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were not provided.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 01-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by the reporter. Vaccine was administered 21 days after first puncture of vial No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received on 28-Sep-2021. Non-significant follow up.
coughing; nauseous; throwing up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (159558). The reporter is the patient.  A 69-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 19Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing); "COPD" (unspecified if ongoing); "COVID" (unspecified if ongoing), notes: She had COVID and was in a hospital for almost 2 weeks. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed (MANUFACTURER UNKNOWN)), for COVID-19 immunization. The following information was reported: COUGH (non-serious), outcome "unknown", described as "coughing"; NAUSEA (non-serious), outcome "unknown", described as "nauseous"; VOMITING (non-serious), outcome "unknown", described as "throwing up".  Additional information: She mentioned that she was diabetic and had COPD. She also mentioned that she had COVID and was in a hospital for almost 2 weeks. The reporter had the Bivalent vaccine (Gray cap, Original/Omicron BA.4/BA.5 (Bivalent), greater than and equal to 12 years, 15/15 mcg per dose) yesterday and experienced adverse reaction, she was nauseous, coughing and throwing up. She wanted to know if that was normal and know if these were reported side effects from the vaccine. Hence reporter asked if the symptoms she had could be caused by the vaccine or by the infection of COVID that she had. The case was reported as Non-serious.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given a 2nd dose of the Moderna Bivalent vaccine but the pharmacy standing order states that the patient should have only gotten one.
approx 20min p/vax arm started to feel numb;upper arm tender to touch, equal bilat hand grasps, pain w/ROM in lt arm;no  notable edema or redness @ site of inj;
I don't know what the type of pneumonia shot was. Experienced flu-like symptoms including extreme fatigue, fever, aches and head-ache. Its now day three and I still feel somewhat sick. Extreme pain at shot site: a number 6 on a scale 1-10.
Hurt to move her arm; Got a little fever on it; Her arm was starting to get sore again where she got the shot; Her arm was real sore, then very painful; Her arm itched like crazy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm was real sore, then very painful), PRURITUS (Her arm itched like crazy), VACCINATION SITE WARMTH (Got a little fever on it), PAIN (Hurt to move her arm) and VACCINATION SITE PAIN (Her arm was starting to get sore again where she got the shot) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Itching.    Concurrent medical conditions included Hypertension (HIgh blood pressure) and Hypercholesterolaemia (High cholesterol).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm was real sore, then very painful) and PRURITUS (Her arm itched like crazy). On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (Her arm was starting to get sore again where she got the shot). On 13-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Got a little fever on it). On 14-Mar-2021, the patient experienced PAIN (Hurt to move her arm). On 17-Mar-2021, PAIN IN EXTREMITY (Her arm was real sore, then very painful), PRURITUS (Her arm itched like crazy), VACCINATION SITE WARMTH (Got a little fever on it), PAIN (Hurt to move her arm) and VACCINATION SITE PAIN (Her arm was starting to get sore again where she got the shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used included high blood pressure medication NOS and high cholesterol medication NOS.